business.financialpost.com
Zymeworks and GSK Expand 2016 Azymetric™ Bispecific Agreement
VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that GSK has expanded its…